Publicaciones

Sanchez AM*, Flamini MI, Zullino S, Russo E, Giannini A, Mannella P, Naccarato AG, Genazzani AR, Simoncini T*. Regulatory actions of LH and FSH on breast cancer cells and mammary tumors in rats. Frontiers in Endocrinology, 2018. 16; 9:239. *Corresponding Author. IF: 3.519. Q1.

Vanderhoeven F, Martinez AL, Redondo AL, Vargas-Roig LM, Sanchez AM, Flamini MI. Synergistic antitumor activity by combining Trastuzumab with retinoic acid in HER2 positive human breast cancers cells. Oncotarget, 2018. Vol 9, 41, 29 26527-26542. IF: 5.168. Q1.

Uzair ID, Conte Grand J, Flamini MI, Sanchez AM. Molecular actions of thyroid hormone on breast cancer cells migration and invasion via Cortactin/N-WASP. Frontiers in Endocrinology. Article collection “Non genomic actions of thyroid hormones in cancer”. 2019, doi: 10.3389/fendo.2019.00139. IF: 3,675. Q1.

Uzair ID, Flamini MI, Sanchez AM. Molecular basis of dendrite spine formation trigger by E2 and P4 via Cortactin/WAVE1/Arp2-3 complex. Neuroendocrinology, 2019. doi: 10.1159/000503310. IF: 6,804.

Mondaca JM, Castro Guijarro AC, Flamini MI, Sanchez AM. Heregulin‑induced cell migration is prevented by trastuzumab and trastuzumab‑emtansine in HER2+ breast cancer. Breast Cancer Research and Treatment. Jan 2021. https://doi.org/10.1007/s10549-020-06089-0. IF: 4.872. Q1.

Mondaca JM, Uzair ID, Castro Guijarro AC, Flamini MI, Sanchez AM. Molecular basis of LH on breast cancer cell migration and invasion via kinase and scaffold proteins. Frontiers in Cell and Developmental Biology, Molecular and Cellular Oncology Section, Special Topic. 2021 Feb 5;8:630147. doi: 10.3389/fcell.2020.630147. eCollection 2020). IF: 6.081. Q1.

Castro Guijarro AC, Vanderhoeven F, Mondaca JM, Fernandez-Muñoz JM, Vanderhoeven F, Uzair ID, Redondo AL, Zoppino FCM, Sanchez AM*, Flamini MI*. Combination treatment of retinoic acid plus focal adhesion kinase inhibitor prevents tumor growth and breast cancer cell metastasis. Cells. *Corresponding Author. IF: 7.66. Q1.